Gene Query: AHCTF1

Dataset Description Geneva Score
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 47.47
Selective suppression of endothelial cytokine production by progesterone receptor 46.27
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 46.27
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 42.55
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 40.34
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 35.42
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 33.99
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 29.74
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 29.21
Genes significantly down or Up-regulated upon RNF219 knockdown 29.13
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 28.77
Recovery and analysis of nascent RNA 28.77
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 23.22
High-throughput sequencing of PROMPT-enriched samples. 23.11
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 22.74
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 22.2
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 19.92
hTERT promotes cell adhesion and migration independent of telomerase activity 19.85
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 19.63
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 19.35
Human cell line and subcutaneous tumor 18.98
Disruption of the exocyst induces podocyte loss and dysfunction 18.62
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 18.37
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 18.08
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 17.96
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 17.87
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 17.8
SLAM-seq for K562 endogenous mRNA decay 17.8
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 17.36
R430: A potent inbibitor of DNA and RNA viruses 17.23
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 17.22
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 17.16
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 17.11
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 16.6
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 16.51
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 16.49
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 15.87
Regulation of highly expressed hCINAP on translatome 15.84
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 15.48
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 15.38
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 15.38
Profiling of escape kinetics of viruses subjected to RNAi 15.36
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 15.35
Survival of pancreatic cancer cells lacking KRAS function 14.87
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 14.73
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 14.65
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 14.59
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 14.46
Uridylation by TUT4 and TUT7 marks mRNA for degradation 14.28
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 14.0
Human neutrophil genome during PMA- and E. coli encounter-induced activation 14.0
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 13.98
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 13.88
Targeting EZH2 in MYCN-amplified Neuroblastoma 13.86
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 13.86
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 13.82
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 13.76
RNA sequencing of mechanically strained NHEKs and control NHEKs 13.76
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 13.67
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 13.62
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 13.62
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 13.6
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 13.55
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 13.51
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 13.45
Differential expression of genes in AD169-infected MRC5. 13.44
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 13.43
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 13.4
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 13.33
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 13.33
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 13.16
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 13.13
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 13.04
Ribosomal footprinting of CN34-Parental and CN34-LM1a 13.04
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 13.04
HNRNPL and its RNA Targets in Prostate Cancer 13.04
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 12.98
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 12.92
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 12.92
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 12.88
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 12.88
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 12.88
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 12.88
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 12.77
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 12.77
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 12.75
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 12.65
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 12.65
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 12.57
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 12.42
Global Mapping of Human RNA-RNA Interactions 12.33
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 12.2
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 12.2
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 12.19
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.18
Control of prostate tumour growth by the long non-coding RNA GHSROS 12.11
3’ Uridylation Expands miRNA Target Repertoire 12.11
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 12.03
Determination of tRNA aminoacylation levels by high throughput sequencing 12.02
RNA-sequencing in irradiated and normal A549 cells. 11.96
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 11.94
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 11.87
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 11.87
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 11.84
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 11.82
An RNA-centric dissection of host complexes controlling flavivirus infection 11.79
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 11.79
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 11.77
G-quadruplex structures mark human regulatory chromatin 11.73
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 11.68
Regulatory network controlling tumor-promoting inflammation in human cancers 11.68
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 11.68
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 11.66
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 11.62
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 11.61
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 11.59
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 11.55
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 11.48
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 11.47
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 11.38
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 11.35
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 11.34
FOXD3 is a novel tumor suppressor in lung cancer 11.34
Ribosomal footprinting of MDA-Parental and MDA-LM2 11.33
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 11.28
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 11.28
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 11.21
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 11.14
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 11.08
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 11.07
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 11.03
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 10.96
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 10.88
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 10.83
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 10.83
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 10.81
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 10.8
Effect of PBK knockdown on C4-2 cell transcriptome 10.8
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 10.76
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 10.76
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 10.75
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 10.75
MCF10A H-Ras RNA-Seq 10.71
MicroRNA targetome analysis during HCMV infection 10.71
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 10.66
hnRNP C is a key regulator of protein synthesis in mitosis 10.65
Effect of disulfiram treatment on pediatric high grade glioma 10.58
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 10.55
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 10.54
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 10.54
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 10.53
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 10.5
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 10.47
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 10.47
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 10.45
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 10.36
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 10.34
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 10.33
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 10.31
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 10.31
Transcriptome of diurnal human blood neutrophils 10.25
Sensing self and nonself circular RNAs 10.18
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 10.17
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 10.15
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 10.14
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 10.14
MYC dependent mRNA translation shapes gene expression and cell biology 10.12
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 10.1
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 10.09
Transcriptomic analyssis following EHMT1/2 inhibition 10.09
10.09
MeRIP-seq for heat shock in B-cell lymphoma cells 10.08
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 10.02
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.0
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 9.92
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 9.89
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 9.87
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 9.84
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 9.84
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 9.8
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.8
RNA-Seq with and without RNase treatment in PCa cell lines 9.73
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 9.72
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 9.72
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 9.64
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 9.62
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 9.5
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 9.49
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 9.47
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 9.41
Transcription control by the ENL YEATS domain in acute leukemia 9.41
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 9.39
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 9.38
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 9.34
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 9.32
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 9.31
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 9.3
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 9.3
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 9.26
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.17
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.17
The contribution of Alu exons to the human proteome 9.15
Genetic-to-epigenetic Therapy for Pancreatic Cancer 9.12
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 9.12
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 9.12
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 9.09
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 9.08
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 9.07
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 9.02
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 8.95
4sU-seq of HFF exposed to salt and heat stress 8.92
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 8.91
Pharmacologic inhibition of STAT5 in AML 8.91
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 8.81
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 8.76
Transcriptome analysis of U87 cells upon LINC00152 knockdown 8.71
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 8.71
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 8.65
The MEF2B Regulatory Network 8.62
The MEF2B Regulatory Network - RNA-seq data 8.62
NHLRC1 re-expression in cancer cells 8.62
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 8.52
Tpl-2 small molecule project 8.49
Tpl-2 and MEK small molecule inhibitors 8.49
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 8.48
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 8.43
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 8.4
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 8.39
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 8.35
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 8.31
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 8.27
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 8.26
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 8.26
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 8.25
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 8.22
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 8.2
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 8.2
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 8.19
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 8.04
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 7.98
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 7.96
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 7.93
Global response to chemotherapy-induced apoptosis 7.91
RNA-seq melanoma 7.91
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 7.88
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 7.83
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 7.82
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 7.76
Mutational landscape of splicing genes and functional consequences across 33 cancer types 7.69
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 7.58
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 7.57
Aneuploidy triggers an immune response 7.57
Biological effect of chronic mistranslation in mammalian cells 7.54
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 7.5
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 7.48
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 7.48
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 7.48
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 7.47
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 7.34
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 7.33
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 7.33
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 7.31
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 7.26
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 7.19
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 7.18
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 7.05
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 7.04
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 6.98
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.95
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 6.87
Induced DNA demethylation, genome instability and transcription 6.87
Transcriptomes of oxLDL exposed trained monocytes 6.85
oxLDL exposed trained monocytes 6.85
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 6.85
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.84
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 6.77
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.67
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 6.66
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.64
The cohesin release factor WAPL restricts chromatin loop extension. 6.6
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 6.6
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 6.59
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 6.47
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 6.41
Cell responses to dysregulated VZV-induced cell-cell fusion 6.38
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 6.31
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 6.27
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 6.25
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 6.25
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.24
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.24
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 6.24
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 6.12
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 6.11
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.11
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 6.0
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 6.0
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.91
RNA-seq of RKO cells with cTAZ KO or putback 5.79
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 5.77
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 5.77
Dysregulated immune system networks in war veterans with PTSD 5.73
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 5.55
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 5.46
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.42
Capturing the Interactome of Newly Transcribed RNA 5.39
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.39
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 5.32
Noncoding regions are the main source of targetable tumor-specific antigens 5.28
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.26
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.26
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 5.25
Exploring ILF2 regulatory genes by next-generation sequencing 5.24
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 5.17
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.11
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 5.07
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 5.02
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 5.02
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.96
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 4.93
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.87
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 4.83
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.79
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 4.77
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 4.76
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 4.76
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 4.76
UV_24h_GRO-Seq 4.73
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.67
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 4.67
Transcriptome analysis of SKI knock-out in HL60 cells 4.67
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.65
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 4.64
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.64
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 4.58
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 4.58
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.55
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 4.48
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 4.48
Defective structural RNA processing in relapsing-remitting multiple sclerosis 4.47
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.42
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 4.39
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 4.39
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.39
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.39
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 4.37
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.32
Iron response of HepG2 cells 4.26
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 4.24
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 4.23
Identification of renal resident macrophages across species [C1] 4.19
Targeting MTHFD2 in Acute Myeloid Leukemia 4.18
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 4.08
Universal alternative splicing of noncoding exons 3.94
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.9
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.83
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.8
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.75
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.74
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.73
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.7
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 3.63
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 3.63
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.43
A code of mono-phosphorylation modulates the function of RB. 3.41
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 3.38
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 3.37
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.28
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 3.27
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 3.27
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.26
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.2
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.17
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.13
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.13
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 3.02
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.0
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.99
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 2.98
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.97
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.93
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.93
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.85
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 2.8
RNA-Seq of PRMT1 overexpression ECA109 cells 2.79
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.79
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 2.72
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.71
Next generation sequencing of small RNAs isolated from exosomes in human semen 2.71
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.7
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.7
Copper Regulation of HIF-1 Transcription Activity 2.7
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.7
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.68
Transcriptome sequencing of K-562 cells 2.68
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 2.64
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 2.57
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.55
Small-molecule targeting of brachyury transcription factor addiction in chordoma 2.51
Gene expression analysis of human hepatocellular cancers 2.46
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 2.41
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.33
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.31
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 2.28
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.25
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 2.24
WNT signaling memory is required for ACTIVIN to function as a morphogen 2.24
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.23
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.2
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.2
RNA-seq analysis of control and Myc-induced U2OS cells 2.17
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.16
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.15
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  2.13
Transcriptome of U251 cells overexpression complement component 7 2.13
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.1
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 2.07
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 2.04
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 2.04
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 2.02
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 2.02
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 2.0
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 2.0
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.98
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 1.83
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 1.83
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.77
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 1.7
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.64
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.58
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.58
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.56
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.55
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.55
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.51
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.48
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.48
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 1.43
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.39
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.33
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.31
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.31
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.31
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.25
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.24
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.24
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.23
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.14
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.13
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.1
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.04
The DPYSL2 gene connects mTOR and schizophrenia 1.03
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.01
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.0
Effects of transcription on genome - nuclear lamina interactions 1.0
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.0
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 1.0
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.95
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.94
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 0.93
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.92
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.8
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.8
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.78
The role of the Calcium-Sensing receptor in colorectal cancer 0.72
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.68
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.68
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.67
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.67
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.64
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.63
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.61
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.51
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.48
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 0.48
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.44
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.37
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.37
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 0.36
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.35
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 0.27
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.2
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.2
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 0.18
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.18
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.16
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.13
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.13
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.12
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.1
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.1
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.1
Modulation of nonsense-mediated decay by rapamycin 0.1
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 0.07
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.06
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.06
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.03
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.03
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation